Linear Clinical Research
Linear Clinical Research is a Perth-based not-for-profit early-phase clinical trials site, wholly owned by the Harry Perkins Institute of Medical Research, conducting first-in-human, healthy volunteer, oncology, and haematology studies for global pharmaceutical and biotech sponsors across four interconnected facilities.
- Company typePrivate
- Founded2010
- HeadquartersPerth, Australia
- Headcount51–100
- GTM typeB2B
- OfferingServices
What Linear Clinical Research does
Linear Clinical Research is a private, not-for-profit early-phase clinical trials site headquartered in Nedlands (Perth), Western Australia, operating as a wholly owned subsidiary of the Harry Perkins Institute of Medical Research. Founded in 2010, the organization operates four interconnected facilities, including the Advanced Clinical Trial Centre (ACTC), Australia's first licensed private hospital solely dedicated to next-generation clinical trials, alongside the Joondalup and Nedlands Clinical Trial Centres and the Hampden House administrative hub. Linear conducts Phase 1 through Phase 4 trials with deep specialization in first-in-human, healthy volunteer, oncology, and haematology studies, including CAR-T cell therapy and other cellular therapies, leveraging 66 healthy volunteer beds plus 18 ACTC beds with six overnight capabilities.
The company serves three primary customer segments: pharmaceutical and biotechnology sponsors seeking to run early-phase trials in Australia, healthy volunteers who participate in paid studies for compensation exceeding $500 per night, and cancer patients referred by medical specialists for access to cutting-edge therapies. Revenue is generated through negotiated per-trial professional services contracts with sponsors, supplemented by donations through its Deductible Gift Recipient status. Linear monetizes Australia's structural clinical trial advantages, including the TGA Clinical Trial Notification scheme (enabling start-up 4-6 months faster than US counterparts) and refundable R&D tax offsets of up to 43.5%, alongside internationally recognized Medical Directors in oncology and haematology, ICH-GCP/FDA/EMA compliance, and a 450+ trial track record with 126 publications in 2024.
Distribution is omnichannel: a dedicated business development team engages sponsors globally, world-renowned CRO partnerships extend reach, a self-serve online portal recruits from a 75,000+ volunteer database, and medical specialist referral networks funnel cancer patients to the ACTC. The organization is led by CEO Jayden Rogers with a full executive bench (CFO, CBDO, CPCTO) and governed by a Board chaired by Roger Port, including representatives of the parent Harry Perkins Institute and independent directors with Big Four and major healthcare backgrounds. Linear is positioned as Australia's leading early-phase clinical trial export platform, with operations concentrated in Western Australia but customer relationships spanning global pharma and biotech sponsors.
Linear Clinical Research firmographics
Firmographics- Name
- Linear Clinical Research
- Legal name
- Linear Clinical Research Ltd
- Website
- https://linear.org.au
- Company type
- Private
- Founded year
- 2010
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Linear Clinical Research is a Perth-based not-for-profit early-phase clinical trials site, wholly owned by the Harry Perkins Institute of Medical Research, conducting first-in-human, healthy volunteer, oncology, and haematology studies for global pharmaceutical and biotech sponsors across four interconnected facilities.
- Ownership category
- akta.pro rank
Linear Clinical Research industry classification
Industry- Product category
- Early-Phase Clinical Trial Services
- NAICS
- Research and Development in the Physical, Engineering, and Life Sciences (54171), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Medical Laboratories (621511)
- SIC
- Services-Health Services (8000), Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734)
- akta.pro primary industry
- Clinical Trial Site Operations & Study Coordination (HLAGACAE)
- akta.pro secondary industries
- Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays) (HLAAAMAC), Clinical Research & Trial Central Laboratories (HLAFAMAL), Point-of-Care & Decentralized Trial Testing Services (HLAGAEAK)
Keywords
Where Linear Clinical Research is headquartered
LocationHeadquarters
- HQ city
- Perth
- HQ country
- Australia
- HQ region
- Oceania
Offices4 records
Markets served
Linear Clinical Research business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain
Revenue model
- Clinical Trial Services for Sponsors: Linear generates revenue by conducting clinical trials on behalf of pharmaceutical and biotech sponsors. Services include Phase 1-4 trial management, protocol development, participant recruitment, and regulatory compliance support.
- Participant Payments (Cost Recovery): Healthy volunteers are paid over $500 per night for participating in clinical trials. Payments vary based on trial length, visit frequency, and study complexity. Payments are approved by independent ethics committees.
- Donations and Bequests: Tax-deductible donations from the public to support clinical research. All donations of $2 or more are tax-deductible in Australia. Linear is a registered Deductible Gift Recipient.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Healthy Volunteer Clinical Trials |
| Transaction based/ take rate | Pay-as-you-go | Referral Bonus Program |
| Other | Multi-year contract | Sponsor Clinical Trial Services |
Go-to-market motion4 records
Distribution channels3 records
Marketing channels6 records
Linear Clinical Research product offering
Product offeringCore offering
Linear Clinical Research is a not-for-profit early-phase clinical trial provider operating four interconnected facilities in Perth, Western Australia. It executes Phase 1–4 trials for pharmaceutical and biotechnology sponsors, with core specialisation in first-in-human, healthy volunteer, oncology, and haematology studies. The company recruits participants through a 75,000+ volunteer database and medical specialist referrals, delivering ICH-GCP-compliant trials leveraging Australia's TGA Clinical Trial Notification scheme.
Product overview
Linear Clinical Research is a life-science organisation operating a unified clinical trial services platform consisting of four interconnected facilities (Advanced Clinical Trial Centre, Joondalup Clinical Trial Centre, Nedlands Clinical Trial Centre, and Hampden House) that deliver early-phase clinical trials spanning first-in-human, healthy volunteer, oncology, and haematology studies. The company offers a comprehensive service portfolio including Phase 1-4 trial conduct, participant screening and recruitment, cancer clinical trials with access to next-generation therapies including CAR-T cell therapy, and strategic protocol development for pharmaceutical and biotechnology sponsors. With over 15 years of experience, 450+ completed trials, and 420+ Phase 1/1b trials conducted, Linear positions itself as a purpose-driven organisation providing end-to-end clinical research services from concept to delivery.
Differentiator
Problem solved
Functional benefit
Products and services
- Early Phase Clinical Trials Phase 1 and 1b clinical trials executed for pharmaceutical and biotechnology sponsors, including first-in-human, first-in-patient, and early-phase studies across multiple therapeutic areas, conducted across Linear's three Perth facilities.
- Healthy Volunteer Clinical Trials Paid overnight and outpatient clinical trials for healthy adult volunteers aged 18+ conducted at the Joondalup and Nedlands facilities, with all meals, accommodation, and Wi-Fi included and per-night compensation exceeding AUD $500.
- Cancer Clinical Trials Oncology and haematology clinical trials including solid tumour, blood cancer, CAR-T cell therapy, and next-generation cellular therapies, delivered at the Advanced Clinical Trial Centre (ACTC) in Nedlands with 18 patient beds and six overnight capabilities.
- Strategic Project Planning and Protocol Development Strategic feasibility, project planning, protocol design, and rapid start-up services for Phase 1–4 sponsor trials, including regulatory submissions, site management, and quality assurance under TGA CTN scheme.
- Participant Screening Services Free health checks and comprehensive medical screening evaluations performed by doctors to determine participant eligibility for healthy volunteer and patient clinical trials, with AUD $100–$250 screening reimbursement where applicable.
- Oncology Patient Referral Service Referral pathway for medical specialists (oncologists and haematologists) to enrol cancer patients into Linear's oncology and haematology clinical trials, facilitated by Medical Directors Professor Michael Millward and Professor Chan Cheah.
Quantifiable outcome
- 94.5% cohorts dosed on time in FY24
- +4 more outcomes
Companies that use Linear Clinical Research
Customer profileNamed customers2 records
Segments4 records
Ideal customer profiles2 records
Linear Clinical Research technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Linear Clinical Research partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered core, major, support and minor.
- Arrowhead PharmaceuticalscoreArrowhead Pharmaceuticals has worked closely with Linear and Professor Gerald Watts across multiple phase I to III cardiometabolic clinical programs. Linear's world-class facilities and Australia's favourable regulatory environment have helped advance these important programs.
- SPARK at StanfordcoreSPARK at Stanford collaborated with Linear on a clinical trial project. According to Professor Daria Mochley-Rosen, they were thoroughly impressed with the world-class service, excellent trial execution, and the project was completed ahead of schedule.
- Clinical Research Organisations (CROs)coreLinear partners with world-renowned Clinical Research Organisations in Australia to deliver high-quality, efficient trials. These trusted collaborations support global drug development across early and late-phase studies.
- Professor Michael MillwardcoreInternationally recognised Medical Director for Oncology overseeing Linear's cancer clinical trials with driving excellence in clinical trials and ensuring highest standards of patient care.
- Professor Chan CheahcoreInternationally recognised Medical Director for Haematology overseeing Linear's cancer clinical trials. Recognised among top 20 lymphoma researchers globally according to Expertscape. Founded Blood Cancer Research WA.
- Blood Cancer Research WAmajorFounded by Professor Chan Cheah in 2018, BCRWA has transformed treatment of blood cancer patients and attracted outstanding researchers from around the world to deliver cutting-edge clinical trials for Western Australian patients.
- Medical Imaging and Diagnostic FacilitiessupportLinear collaborates with top medical imaging facilities to provide seamless access to PET Scanner (FDG/FLT), MRI, CT, X-ray, and other advanced diagnostic technologies for clinical trial participants.
- MedibankminorCorporate health insurance partnership providing Linear employees with 9% discount on private health insurance, along with monthly wellbeing sessions via Medibank's Live Better series.
Scale indicators11 records
Recent moves7 records
Expansion highlights6 records
Linear Clinical Research competitors and assessment
Company assessmentBroad incumbents
- Syneos Health: Global biopharmaceutical services organisation offering clinical development and early-phase services; an established, broader-scope alternative to Linear for sponsors selecting site and CRO partners.
- IQVIA: Global clinical research services provider with extensive Phase 1 capacity and site relationships; competes for the same large pharma sponsor business that Linear pursues, but at global scale.
- ICON plc: Global CRO offering early-phase clinical research services among a broad portfolio; competes for biotech and pharma sponsors seeking early-phase execution but operates at significantly greater scale than Linear.
- Charles River Laboratories: Global CRO with established early-phase and discovery-to-clinical services; competes with Linear in early-stage sponsor mandates while operating a much broader services portfolio.
Direct peers
- Q-Pharm: Brisbane-based early-phase clinical trials facility with specialist Phase 1 capability in vaccines and infectious disease, overlapping directly with Linear's first-in-human and healthy volunteer service lines.
- CMAX Clinical Research: Adelaide-based early-phase clinical trial unit focused on first-in-human and healthy volunteer studies; directly comparable to Linear's Phase 1 core service offering and target sponsor base.
- Novotech: Australia-headquartered full-service CRO with strong early-phase and oncology capabilities across APAC; competes with Linear for sponsor trial placements and shares the Australia-as-trial-destination value proposition.
- Nucleus Network: Australian-headquartered early-phase clinical trial organisation operating Phase 1 units and healthy-volunteer programmes, directly comparable to Linear's specialist Phase 1, healthy volunteer, and oncology trial services in Australia.
- Scientia Clinical Research: Sydney-based early-phase clinical trial unit conducting Phase 1 trials across multiple therapeutic areas; competes with Linear for the same Australian pharma/biotech sponsor relationships.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
Linear Clinical Research social profiles
Digital presenceLinear Clinical Research compliance and trust
Trust signalCompliance10 records
Linear Clinical Research financial estimates
Financial estimateRevenue estimate
Valuation estimate
Linear Clinical Research leadership team
Management profileNumber of profiles
Profiles14 records
Linear Clinical Research funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Linear Clinical Research M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Linear Clinical Research
What does Linear Clinical Research do?
Linear Clinical Research is a not-for-profit early-phase clinical trial provider operating four interconnected facilities in Perth, Western Australia. It executes Phase 1–4 trials for pharmaceutical and biotechnology sponsors, with core specialisation in first-in-human, healthy volunteer, oncology, and haematology studies. The company recruits participants through a 75,000+ volunteer database and medical specialist referrals, delivering ICH-GCP-compliant trials leveraging Australia's TGA Clinical Trial Notification scheme.
Is Linear Clinical Research a public or private company?
Linear Clinical Research is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Linear Clinical Research founded?
Linear Clinical Research was founded in 2010. It employs 51 to 100 people.
Where is Linear Clinical Research based?
Linear Clinical Research is headquartered in Perth, Australia, in the Oceania region.
How does Linear Clinical Research make money?
Three revenue lines are on record. Clinical Trial Services for Sponsors are the primary driver. The others are participant Payments (Cost Recovery) and donations and Bequests.
Who are Linear Clinical Research's main competitors?
Broad incumbents on record are Syneos Health, IQVIA, ICON plc and Charles River Laboratories. Direct peers are Q-Pharm, CMAX Clinical Research, Novotech, Nucleus Network and Scientia Clinical Research.
Does Linear Clinical Research have an API?
No public API is recorded for Linear Clinical Research.
What industry is Linear Clinical Research in?
Linear Clinical Research's product category is Early-Phase Clinical Trial Services. Its primary akta.pro industry code is HLAGACAE, Clinical Trial Site Operations & Study Coordination, with a secondary code of HLAAAMAC, Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays). Its NAICS code is 54171 and its SIC code is 8000.